| Indication | Oncology |
| Status | FDA NDA reviewing |
| Product Advantages | Utilize the novel salt API to enhance the stability of drug absorption by optimizing the physicochemical properties of raw materials and formulations. This approach aims to minimize fluctuations in drug dosage and blood concentration levels. Furthermore, co-administration with food may mitigate both the incidence and severity of adverse effects, thereby improving the overall safety profile of the medication for patients. |
| Potential Market | The branded drug is a multi-target oncological therapy indicated for the treatment of various malignancies, with a significant potential market. According to the 2024 annual report from the branded drug company, net revenue from the U.S. market in 2024 amounted to USD 2.417 billion. |
?
R&D
HND-039
